Notably, as with continuously cultured lines, stromal cells failed to protect primary CD138+ MM cells from the TL/Btz regimen and were also fully active against Btz-resistant cells expressing upregulation of MCL-1 and downregulation of BIM [26]. The gene discussed is BCL2L11; the disease is Miyoshi myopathy.